By Anton Ladnyi, CFA · ex-Goldman Sachs · ex-J.P. MorganPublished Updated
Custom silicon leader for hyperscaler AI — FY2028 guidance raised to $16.5B (+10% in 3 months) as co-packaged optics and ASIC ramps accelerate
MRVL Price Target & Rating
MRVL's quantitative grade is Reduce, with moderate downside risk (CVaR -18.0%), and quality metrics (net margin 29%, ROE 16%). Marvell Technology Inc. (MRVL) trades at $205.00 with a valuation grade of Reduce: a trailing P/E of 70.4x at a 120% premium to sector median, net margins of 29.0%, a DCF-implied intrinsic range of $94–$249 suggesting a -16% margin of safety, beta 2.25 (highly aggressive risk profile).
DCF Valuation Range
Key Takeaways
Valuation: Reduce grade — P/E 70.4x — DCF range $94–$249 implies -16% margin of safety
Risk: CVaR -18.0% (95th percentile, 1-month) indicates moderate tail exposure; beta of 2.25 amplifies broad market moves in both directions
Strengths: Quality 5.0/5, Size 4.0/5, 29% net margin, 16% ROE dominate the factor profile
Bear catalyst: FY2028 guidance cut below $14B OR hyperscaler capex pause signals ASIC program delays
MRVL — Quantitative SnapshotMay 2026
RatingReduce
Price$205.00
Why ReduceModestly above estimated intrinsic value — risk/reward skewed to the downside at current price; watch for a pullback to the Hold boundary
Main riskP/E of 70.4x creates asymmetric downside on any earnings disappointment
Tail riskCVaR -18.0% over one month at the 95th percentile
DCF range$94–$249 intrinsic range; margin of safety -16%
Best useCore large-cap Technology holding — not a source of diversified sector exposure
Next watchEarnings surprise deceleration trend — monitor next quarter delivery closely
Quantitative Factor Profile
Value
2.0 / 5
Quality
5.0 / 5
Momentum
3.0 / 5
Volatility
2.0 / 5
Size
4.0 / 5
Key Metrics
MRVL Key Metrics — Marvell Technology Inc. 2026
Metric
Value
Current Price
$205.00
P/E Ratio (TTM)
70.4x
Forward P/E
34.0x
P/S Ratio
20.6
EV/EBITDA
66.7
Beta
2.25
Net Margin
29.0%
ROE
16.0%
Debt/Equity
29.0%
Dividend Yield
0.12%
CVaR (95%, 1M)
-18.0%
Market Cap
$179.5B
Analyst View
Anton Ladnyi, CFA · A.L. Capital AdvisoryUpdated 2026-05-30
Rating Rationale
Custom silicon leader for hyperscaler AI — FY2028 guidance raised to $16.5B (+10% in 3 months) as co-packaged optics and ASIC ramps accelerate
Investment Thesis
↑ Bull Case
FY2028 revenue guidance raised to $16.5B (from $15B, 10% raise in just 3 months) — momentum vs. prior forecasts accelerating
Data center segment guided 55% YoY growth in FY2028; custom silicon alone >$2B quarterly run-rate by H2 FY2027
Amazon Trainium 3 and Google TPU custom ASIC programs anchoring multi-year revenue visibility with top hyperscalers
Co-packaged optics (CPO) — early commercial deployment with Microsoft; positions MRVL as 800G→1.6T upgrade cycle leader
Analyst PT consensus $220–$275 (average ~$248); meaningful upside from current levels on AI infrastructure ramp
Ethernet switching silicon (Teralynx) gains traction as AI clusters scale beyond InfiniBand-only architectures
↓ Bear Case
Hyperscaler ASIC customers (Amazon, Google) could vertically integrate further, limiting MRVL's design role
Networking business (non-data center) remains under pressure from soft enterprise capex
Valuation pricing significant growth — any execution miss or macro slowdown amplifies multiple compression
TSMC advanced node allocation risks if supply tightens across AI chip ecosystem
Intel Foundry or Samsung custom silicon winning a key hyperscaler program is tail risk
What Changes the Rating
↑Catalyst:Third hyperscaler ASIC program announced OR CPO revenue crosses $500M annual run-rate
↓Stop / exit:FY2028 guidance cut below $14B OR hyperscaler capex pause signals ASIC program delays
Anton’s personal note
The rating on MRVL is driven by a factor profile that is genuinely mixed — there is no clean narrative here, which is itself a signal worth taking seriously. What I watch on this name is earnings consistency — specifically whether delivery against consensus is stable or deteriorating. That is usually where the rating gets confirmed or challenged before the price reflects it. The scenario that changes my read is a genuine valuation reset — not a small pullback, but a re-rating that reflects the actual risk profile. Until that happens, the risk/reward is not there.
— Anton Ladnyi, CFA
Earnings History
MRVL Earnings History — EPS Surprise Rate 2026
Quarter
EPS Est.
EPS Actual
Surprise
Q1 FY2027
$0.80
$0.80
+0.6% ✓
Q4 FY2026
$0.79
$0.80
+1.1% ✓
Q3 FY2026
$0.74
$0.76
+3.0% ✓
Q2 FY2026
$0.67
$0.67
-0.5% ✗
Quarterly EPS — Estimate vs Actual
Earnings Projections
MRVL Forward EPS Consensus Estimates 2026
Quarter
EPS Est.
YoY EPS
Analysts
Q2 FY2027
$0.93
+38.8%
30
Q3 FY2027
$1.07
+40.8%
30
Q4 FY2027
~$1.99
+148.8%
32
Q1 FY2028
~$1.51
+88.8%
40
~ Estimated from annual consensus — not a direct analyst survey
MRVL — P/E 70.4x · Beta 2.25 • Quantitative grade: Reduce • CVaR from one-year daily history · historical simulation
DCF Scenario Analysis
Hover each scenario for detail · current price $205.00
▼
Bear Case
$95
-53.7%
Fwd P/E: 17.3x
18% revenue CAGR · 28 exit multiple
◆
Base Case
$175
-14.6%
Fwd P/E: 31.8x
32% revenue CAGR · 38 exit multiple
▲
Bull Case
$290
+41.5%
Fwd P/E: 52.7x
45% revenue CAGR · 50 exit multiple
Pairwise Correlation Matrix
0 of 10 peer pairs correlated above 0.60 — diversification benefit within this cluster is structurally limited.
Extended Analysis — Buy, Hold or Sell? Risk Factors. Portfolio Fit.
Is MRVL a buy, hold, or sell?
MRVL carries a valuation grade of Reduce. The trailing P/E of 70.4 sits 120% above the Technology sector median of 32.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $94–$249 — implying a -16% margin of safety at the current price of $205.00. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 9% beat rate on recent quarters, earnings predictability has been mixed. Analyst estimate revisions are trending upward.
What are MRVL's key risk factors?
With a beta of 2.25, MRVL exhibits a highly aggressive risk profile relative to the broad market. The 95th-percentile CVaR of -18.0% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.8% of total portfolio loss in the worst 5% of months. Net margins of 29.0% are significantly above the Technology sector average of 22%, reflecting durable pricing power. Return on equity of 16.0% suggests solid capital efficiency. The balance sheet is conservatively leveraged at 29% debt-to-equity.
A put/call ratio of 1.08 indicates roughly balanced sentiment in the options market. Implied volatility of 93.5% exceeds realized volatility of 65.8% by 28 points, suggesting options are pricing in elevated risk. Insiders have been net sellers to the tune of $60.6M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 4.3% of float, suggesting limited bearish conviction.
How does MRVL fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — MRVL carries a beta of 2.25, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, MRVL shows the strongest co-movement with AVGO (0.43), AMD (0.42), NVDA (0.36). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The MRVL analysis here is a single node in that larger structure.
Marvell Technology Inc. (MRVL) carries a Reduce quantitative rating from A.L. Capital Advisory, derived from Discounted Cash Flow intrinsic value analysis, five-factor model scoring (Value, Quality, Momentum, Volatility, Size), and CVaR tail risk measurement. At $205.00, the DCF midpoint margin of safety is -16% (intrinsic value range: $94 bear – $249 bull). Composite factor score: 3.2/5. Strongest factor: Quality (5.0/5). Weakest factor: Value (2.0/5). Trailing P/E: 70.4x. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Portfolio Construction Framework →
What is the average analyst target price for MRVL?
Wall Street consensus target for MRVL: $215.41 (+5.1% upside from the current price of $205.00). The analyst target range spans $110.00 (most bearish) to $300.00 (most bullish). Consensus recommendation: Strong Buy. Note that analyst price targets typically reflect a 12-month forward horizon and are derived from a blend of DCF, comparable-company, and sum-of-the-parts analysis. A.L. Capital Advisory’s quantitative Reduce rating is produced independently — from DCF intrinsic value, five-factor model scores, and CVaR tail risk — and does not mechanically track Street consensus. When the two diverge, the divergence itself is informative: it can reflect differences in time horizon, valuation methodology, or the degree to which the current price already discounts the consensus case. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Monte Carlo Simulation Framework →
How does MRVL score on Value, Quality, Momentum, Volatility, and Size?
MRVL five-factor scores (A.L. Capital Advisory, 1–5 scale): Value 2.0/5 (below average) — measures current price versus DCF intrinsic range and trailing earnings multiples; Quality 5.0/5 (strong) — captures profitability metrics including return on equity, net margin (ROE: 16.0%) and net margin (29.0%); Momentum 3.0/5 (neutral) — reflects recent price trajectory and earnings surprise consistency; Volatility 2.0/5 (below average) — inverse measure derived from beta, where lower historical volatility earns a higher score; Size 4.0/5 (above average) — market capitalisation rank (mega-cap $1T+ scores 5/5). Composite: 3.2/5. Factor scores above 4.0 signal a tailwind in that dimension; below 2.0 signals a material headwind. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Black-Litterman Model →
What is MRVL's tail risk and CVaR?
The 95th-percentile Conditional Value at Risk (CVaR) for MRVL on a one-month horizon is -18.0%. CVaR represents the expected average loss in the worst 5% of monthly outcomes — a more conservative tail risk measure than standard VaR, which only marks the loss threshold. Beta of 2.25 indicates above-market volatility with amplified drawdown exposure. For reference, a diversified S&P 500 ETF carries a one-month CVaR of roughly -8% to -12% in normal market conditions; individual equity CVaR is higher due to idiosyncratic risk. At the portfolio level, what matters is the marginal CVaR contribution of each holding — not its standalone figure. The A.L. Capital Advisory Portfolio Health Check quantifies each position's marginal tail-risk contribution across your entire holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: CVaR & Tail-Risk Methodology →
What is MRVL's intrinsic value and DCF price target?
A.L. Capital Advisory's DCF model produces an intrinsic value range of $94 (bear case) to $249 (bull case) for Marvell Technology Inc. (MRVL). At $205.00, the midpoint margin of safety is -16% (positive = discount to intrinsic mid; negative = premium). The bear-to-bull spread reflects genuine sensitivity to the two dominant DCF inputs: the terminal growth rate and WACC. Terminal value typically accounts for 60-80% of total intrinsic value in most equity DCF models, which is why a range is more analytically sound than a point estimate. The central analytical question is not what the DCF outputs as a single number but which growth trajectory the current market price already discounts. All DCF analysis follows CFA Institute standards and is conducted by Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →
What would trigger a rating upgrade or downgrade for MRVL?
Upgrade trigger: Upgrade to Strong Buy on evidence of accelerating earnings surprise magnitude combined with improvement in the Value factor score — specifically if the current 70.4x P/E is supported by an upward revision to DCF terminal growth assumptions. Downgrade trigger: Continued earnings misses or deteriorating balance sheet quality reducing the Quality factor score below 2.0/5. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Investment Policy Statement Framework →
How does MRVL contribute to portfolio risk and diversification?
MRVL carries a beta of 2.25 (high-volatility / growth-sensitive relative to the broad equity market). A beta above 1.0 means the position amplifies market moves in both directions at a typical portfolio weight. Strongest peer co-movement: AVGO (0.43), AMD (0.42), NVDA (0.36). Holding MRVL alongside these names in the same portfolio increases concentration risk. True portfolio risk is a function of the full covariance structure — a single stock's beta does not reveal its marginal contribution to portfolio tail loss. The A.L. Capital Advisory Portfolio Health Check quantifies concentration risk (Herfindahl-Hirschman Index), pairwise correlations, and marginal CVaR contribution across all your holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Ledoit-Wolf Covariance Framework →
What quantitative methodology does A.L. Capital Advisory use to analyse MRVL?
A.L. Capital Advisory analyses Marvell Technology Inc. (MRVL) using a four-component quantitative framework grounded in CFA Institute standards. (1) DCF Valuation: projects free cash flows under bear and bull assumptions, discounts at WACC to produce an intrinsic value range with margin-of-safety calculation. (2) Five-Factor Scoring: each equity is scored 1–5 on Value, Quality, Momentum, Volatility, and Size. (3) CVaR Tail Risk: 95th-percentile Conditional Value at Risk from historical simulation of daily returns on a one-month horizon. (4) Earnings Surprise Analysis: quarterly beat rate and magnitude are incorporated into the Momentum and Quality factor scores. The current Reduce rating for MRVL is the output of applying this complete framework to current data. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework → · CVaR & Tail-Risk Methodology →
Stress-Test This View Live
Run MRVL in Asset Lens
Live DCF valuation, Monte Carlo simulation, options flow intelligence, and full factor decomposition — updated in real time. Free, no account required.
This analysis is produced using a systematic quantitative framework applied to market data and does not constitute investment advice. Prose commentary is AI-assisted and generated from structured quantitative inputs. All data and metrics are as of 2026-05-30 and are point-in-time estimates subject to revision without notice. CVaR figures are based on historical simulation and do not guarantee future outcomes. DCF ranges and upgrade/downgrade triggers are forward-looking statements based on current assumptions and may not materialise. Past performance does not guarantee future results. This analysis does not account for individual circumstances, tax position, or investment objectives — consult a qualified financial advisor before making investment decisions. This content is intended for informational purposes only and does not constitute regulated investment advice under MiFID II or FCA guidelines. This content is not intended for US persons or residents of jurisdictions where its distribution would be contrary to local law or regulation. This service is not directed at residents of Finland, Sweden, Norway, Denmark, Iceland, or Poland. The author may hold long or short positions in securities mentioned in this analysis. Nothing on this page represents a solicitation to buy or sell any security. A.L. Capital Advisory is an independent private advisory practice and is not affiliated with Marvell Technology Inc.
CFA Portfolio Advisory — MRVL
Discuss this analysis, position sizing, or your full portfolio mandate with Anton Ladnyi, CFA.
